Standout Papers
Immediate Impact
1 by Nobel laureates 68 standout
Citing Papers
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
2025 Standout
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
2025 Standout
Works of Chi-Pang Wen being referenced
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
2012 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Chi-Pang Wen | 208 | 329 | 275 | 910 | 527 | 14 | 2.4k | |
| Esther M. Briganti | 294 | 231 | 336 | 1107 | 475 | 39 | 2.7k | |
| Susan Steigerwalt | 141 | 195 | 284 | 1024 | 1172 | 54 | 2.4k | |
| Brett Plattner | 221 | 325 | 366 | 1588 | 403 | 5 | 3.1k | |
| Min Kuang Tsai | 614 | 409 | 258 | 593 | 582 | 32 | 3.1k | |
| Philip Masson | 247 | 489 | 498 | 1592 | 558 | 47 | 3.9k | |
| Samuel Fatoba | 185 | 331 | 273 | 1351 | 487 | 21 | 2.6k | |
| Hui Ting Chan | 631 | 330 | 237 | 505 | 592 | 9 | 2.7k | |
| A.J. Collins | 163 | 340 | 222 | 1625 | 422 | 25 | 2.5k | |
| Amy Luke | 309 | 651 | 471 | 503 | 599 | 37 | 2.6k | |
| Suzanne Watnick | 260 | 414 | 464 | 2152 | 718 | 50 | 3.5k |
All Works
Loading papers...